Off the wire
• 9 insurgents killed, 6 injured in northern Afghan province  • Kenya forms team to probe senior officials linked to graft  • China welcomes Egypt's application to AIIB  • Two Iranian military advisors killed in U.S. airstrike in Iraq: IRGC  • Roundup: Kenya's tourism hit hard by travel warnings from Western countries  • Top UN official arrives in Sri Lanka for official visit  • 2nd LD Writethru: Framework agreement for Iran nuclear talks not so optimistic: diplomatic source  • Clashes near Libya's Tripoli kill 5  • Landslide kills 10 in Burundi  • Roundup: 4 more Afghans abducted as protesters call for release of abductees  
You are here: 　 Home

China mulls rules for stem-cell research

Xinhua, March 30, 2015 Adjust font size:

China is soliciting public review of a set of new rules on stem-cell research.

According to a document published by the National Health and Family Planning Commission and China Food and Drug Administration, stem-cell clinical trials refer to transplantation of stem-cells for the purpose of disease prevention or research.

The document proposes that all clinical records of stem-cell providers and subjects should be kept for at lease 30 years.

Subjects should be observed after clinical trials to assess long-term safety and effectiveness of the research, said the document.

The document also proposed that stem-cell researchers should help subjects understand the goal of research as well as its risks. It also said subjects should be insured and research should stop once adverse reactions emerge. Endi